Related Experiment Video
Updated: Jun 15, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Glycemic control and complications in type 2 diabetes mellitus
1Department of Clinical Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. markstolar@nwinternist.com
The American Journal of Medicine
|March 9, 2010
Summary
Early intervention in type 2 diabetes is crucial. Prompt management of hyperglycemia and related conditions like glucotoxicity can prevent or delay long-term microvascular and macrovascular complications.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetology
Background:
- Current type 2 diabetes mellitus (T2DM) guidelines rely on glycemic targets, but disease progression and complications vary individually.
- Microvascular complications (nephropathy, retinopathy, neuropathy) correlate with HbA1c, yet macrovascular issues can arise independently and early.
Purpose of the Study:
- To highlight the limitations of current glycemic standards in predicting T2DM complications.
- To emphasize the importance of early, potentially reversible pathophysiologic events like glucotoxicity and lipotoxicity.
- To underscore the need for identifying high-risk T2DM patients for earlier intervention.
Main Methods:
- Review of current understanding of T2DM pathophysiology and complication development.
- Analysis of the relationship between glycemic control (HbA1c) and microvascular vs. macrovascular complications.
- Discussion of early pathophysiologic events and their potential reversibility.
Main Results:
- Macrovascular complications can progress even with HbA1c <7.0% and may occur in undiagnosed patients.
- Macrovascular complications develop early in T2DM and do not correlate linearly with HbA1c.
- Managing hyperglycemia late in T2DM does not improve cardiovascular outcomes, suggesting early intervention is key.
Conclusions:
- Glucotoxicity and lipotoxicity are early, reversible events preceding sustained hyperglycemia and beta-cell dysfunction.
- Prompt management of early T2DM may modify disease course and prevent long-term complications.
- Identifying patients at risk for rapid beta-cell decline and premature complications is essential for effective early treatment strategies.
Related Concept Videos
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...